Beta dose-rate distributions in microscopic spherical tumors for intraperitoneal radioimmunotherapy
Authors:
- 1 August 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 56 (5) , 1495-1506
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1997
- Microdosimetry and radiocurability: modelling targeted therapy with -emittersPhysics in Medicine & Biology, 1996
- Dosimetry of intraperitoneally administered radiolabeled antibodiesMedical Physics, 1993
- Distribution of intraperitoneally injected microspheres labeled with the α-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in miceGynecologic Oncology, 1992
- Therapeutic efficacy of the α-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor modelGynecologic Oncology, 1992
- ESTIMATES OF ABSORPTION OF RADIOFREQUENCY RADIATION BY THE EMBRYO AND FETUS DURING PREGNANCYHealth Physics, 1992
- Dose distributions in regions containing beta sources: Uniform spherical source regions in homogeneous mediaMedical Physics, 1991
- A simplified approach to beta dosimetry for small spheres labelled on the surfacePhysics in Medicine & Biology, 1990
- Dose distributions in regions containing beta sources: Large spherical source regions in a homogeneous mediumMedical Physics, 1988
- Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapyThe International Journal of Applied Radiation and Isotopes, 1984